Fresenius Medical Care AG ADR (FMS) stock hits $22.59: Is it a good time to buy or wait for a dip?

Abby Carey

A share price of Fresenius Medical Care AG ADR [FMS] is currently trading at $22.59, down -0.88%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The FMS shares have lost -4.68% over the last week, with a monthly amount drifted -17.46%, and not seem to be holding up well over a long-time horizon.

From an analyst’s perspective:

Fresenius Medical Care AG ADR [NYSE: FMS] stock has seen the most recent analyst activity on October 15, 2025, when BofA Securities downgraded its rating to a Underperform. Previously, UBS downgraded its rating to Sell on September 02, 2025. On December 02, 2024, upgrade upgraded it’s rating to Neutral. Berenberg started tracking the stock assigning a Buy rating and suggested a price target of $25.60 on November 06, 2024. Morgan Stanley downgraded its rating to a Underweight. HSBC Securities upgraded its rating to Hold for this stock on November 24, 2023. In a note dated November 17, 2023, Societe Generale upgraded a Buy rating on this stock.

Fresenius Medical Care AG ADR experienced fluctuations in its stock price throughout the past year between $21.42 and $30.46. Currently, Wall Street analysts expect the stock to reach $17.85 within the next 12 months. Fresenius Medical Care AG ADR [NYSE: FMS] shares were valued at $22.59 at the most recent close of the market. An investor can expect a potential drop of -20.98% based on the average FMS price forecast.

Analyzing the FMS fundamentals

Trailing Twelve Months sales for Fresenius Medical Care AG ADR [NYSE:FMS] were 21.71B which represents 9.16% growth. Gross Profit Margin for this corporation currently stands at 0.25% with Operating Profit Margin at 0.08%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.03%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.05 and Total Capital is 0.06. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.83.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 22.41 points at the first support level, and at 22.23 for the second support level. However, for the 1st resistance point, the stock is sitting at 22.87, and for the 2nd resistance point, it is at 23.15.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Fresenius Medical Care AG ADR [NYSE:FMS] is 1.36. Also, the Quick Ratio is 1.00, while the Cash Ratio stands at 0.3. Considering the valuation of this stock, the price to sales ratio is 0.60, the price to book ratio is 0.86 and price to earnings (TTM) ratio is 16.39.

MZP News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.